Monday, May 23, 2011
|
| 7:30 a.m. |
Registration Opens |
| 8:00 – 8:45 a.m. |
Continental Breakfast in Exhibit Area |
| 8:45 – 10:00 a.m. |
Plenary Session: “Two Sides of the Deal”
Shiv Krishnan, Ph.D., Senior Director, Partnering and Innovation
sanofi-aventis US, Inc.
Kristin Mulready, Senior Manager, Alliance Management
ImmunoGen
Introduction by Campbell Alliance: Preview of “Dealmaker’s Intentions Survey”
Christopher Apolito, Senior Practice Executive
Campbell Alliance |
| 10:00 – 10:15 a.m. |
Networking Break in the Exhibit Area |
| 10:00 – 12:00 noon |
Ongoing 30-Minute Partnering Sessions |
| 10:15 – 12:00 noon |
Ongoing 15-Minute Company Presentations |
| 12:00 – 1:15 p.m. |
 Plenary Luncheon: “Exploring New Grounds for Pharma: Partnering on Innovation”
Morten Sorgaard, Ph.D., Executive Director & Head Biotechnology Unit, External R&D Innovation (ERDI)
Pfizer, Inc. |
| 1:15 – 1:30 p.m. |
Networking Break in the Exhibit Area |
| 1:30 – 3:00 p.m. |
Ongoing 30-Minute Partnering Sessions |
| 1:30 – 3:00 p.m. |
Ongoing 15-Minute Company Presentations |
| 3:00 – 4:00 p.m. |
Panel Discussion: “Early Technology Deals”
Moderator
Zev Scherl, MBA, General Partner
New Spring Capital
Steve Carchedi, Chief Marketing Officer
GE Healthcare – Medical Diagnostics
Michael Cucolo, Director Technology Transactions, Strategic Transactions Group
Bristol-Myers Squibb Company
Tim Saxon, V.P. Business Development
Arecor
Scott Siegel, Vice President, Business Development
Ezose Sciences Inc.
|
| 4:00 – 5:00 p.m. |
Ongoing 30-Minute Partnering Sessions |
| 4:00 – 5:00 p.m. |
Ongoing 15-Minute Company Presentations |
| 5:00 – 6:00 p.m. |
Networking Cocktail Reception in the Exhibit Area |
| 6:00 – 7:45 p.m. |
 Plenary Dinner & Keynote: “The Merck Model: Bringing our Passion for Science to Partnering”
David Nicholson, PhD, Senior Vice President and Head, Worldwide Licensing and Knowledge Management
Merck
|
| 7:45 – 9:00 p.m. |
Networking Dessert Reception in the Exhibit Area |
Tuesday, May 24, 2011
|
| 8:00 – 8:30 a.m. |
Continental Breakfast in Exhibit Area |
| 8:30 – 10:30 a.m. |
Plenary Session
“Non-Dilutive Funding as a Step Toward Validation Panel”
Moderator
Brenda Gavin, Founding Partner
Quaker BioVentures
Ram May-Ron, Managing Partner
FreeMind Group
Scott T. Megaffin, Senior Vice President, Commercial
Onconova Therapeutics Inc.
Richard Winneker, Ph.D., Senior Vice President, Research
The Leukemia & Lymphoma Society
“Investment Bankers Panel”
Luke Beshar, SVP & CFO
NPS Pharmaceuticals, Moderator
Chris Hite, Global Co-Head, Healthcare Investment Banking
Citigroup
Stephen A. Hurly, Managing Director
Boenning & Scattergood Inc.
John Leone, Partner
Paul Capital Healthcare
Graham A. Powis, Managing Director, Head of U.S. Equity Capital Markets
Lazard Frères & Co. LLC |
| 10:30 – 10:45 a.m. |
Networking Break in the Exhibit Area |
| 10:30 a.m. – 12:30 p.m. |
Ongoing 30-Minute Partnering Sessions |
| 10:45 a.m. – 12:30 p.m. |
Ongoing 15-Minute Company Presentations |
| 12:30 – 1:45 p.m. |
 Plenary Luncheon: “What Big Pharma Wants and What Biotech Can Deliver”
Steven J. Projan, Ph.D., FAAM, Sr. V.P. R&D
Innovative Medicines Head of Infectious Diseases & Vaccines
MedImmune |
| 1:45 p.m. |
Meeting Adjourns |
